Inventor
XIANG ALAN X
US15 patents
⚠️ This page may combine multiple inventors who share the name “XIANG ALAN X”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EFFECTOR THERAPEUTICS INC
10 patentsUS9814718B2Nov 14, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC5 citations83
US9669031B2Jun 6, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC12 citations83
US9382248B2Jul 5, 2016
Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC14 citations83
US10577378B2Mar 3, 2020
EIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC6 citations81
US9957277B2May 1, 2018
eIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC6 citations81
US10793551B2Oct 6, 2020
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
EFFECTOR THERAPEUTICS INC2 citations72
US11130757B2Sep 28, 2021
Crystalline forms of MNK inhibitors
EFFECTOR THERAPEUTICS INC2 citations70
US11952375B2Apr 9, 2024
Crystalline forms of Mnk inhibitors
EFFECTOR THERAPEUTICS INC0 citations60
US11440917B2Sep 13, 2022
EIF4A-inhibiting compounds and methods related thereto
EFFECTOR THERAPEUTICS INC1 citations60
US11286268B1Mar 29, 2022
EIF4E-inhibiting compounds and methods
EFFECTOR THERAPEUTICS INC1 citations57
ANADYS PHARMACEUTICALS INC
4 patentsUS7560544B2Jul 14, 2009
3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
ANADYS PHARMACEUTICALS INC16 citations92
US7709448B2May 4, 2010
Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
ANADYS PHARMACEUTICALS INC13 citations83
US7582626B2Sep 1, 2009
5,6-dihydro-1H-pyridin-2-one compounds
ANADYS PHARMACEUTICALS INC13 citations83
US7528115B2May 5, 2009
Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines
ANADYS PHARMACEUTICALS INC2 citations62